StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Good morning! Slept in today. What did I miss?

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Jul 19, 2021 3:57pm

125 Views

Post# 33570468

RE:RE:Good morning! Slept in today. What did I miss?

What really gets old is every day in the red.

crickets from the company. They are busy "getting the deal" signed off.

Care must had assumed some pull back when the deal was annouced but even they must be unhappy with this.

Down 75% since announcement. 75%!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

what does the stock do when the deal becomes officially done? down another 5%?

I guess we can blame it on the overall performance of the markets though. Sure thats a good excuse.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages